Breaking News

Catalent enters commercial supply agreement

Since 2017, Harm Reduction Therapeutics has been working on a low-cost, OTC naloxone product to act as a critical tool to help stem the loss of life

Dorf Ketal and Lehmann&Voss&Co. expand sales partnership

The LEHVOSS Group under the management of Lehmann&Voss&Co. is a group of companies in the chemicals sector

Synaffix announces licensing agreement with CKD Pharm

Under the terms of the agreement, Synaffix has received an upfront payment and is eligible to receive further milestone payments

CDMOs deliver increased performance for pharma clients with agility and innovation

Emma Verkaik, Membership & Marketing Director at the BCMPA — the Association for Contract Manufacturing, Packing, Fulfilment & Logistics — gleans i...

Lonza reveals strong 2022 performance

The results were driven by strong underlying business performance and a COVID-related sales peak in 2022

Helsinn signs distribution agreement with Immedica Pharma

This allows for the commercialisation of two cancer supportive care products indicated for the prevention of chemotherapy-induced nausea and vomiting

The critical role of temperature monitoring in the pharmaceutical cold chain

The importance of temperature monitoring and control in the pharmaceutical supply chain has never been so keenly recognised. In the following artic...

Lonza completes expansion to SFS

The expanded facility in Bend, Oregon (US) became fully operational in Q4 2022

Get ahead of the curve in 2023 with a subscription

Keep abreast of significant pharmaceutical developments around the world

Supply chain innovation and digitalisation: primary packaging as a disruptive factor

Bormioli Pharma, an international leader in the production of glass and plastic containers for pharmaceutical use, has developed a number of option...

Orion and Amneal enter distribution partnership

The initial portfolio will include a mix of generic products commercially available in the US today

CPHI Annual Report: Building a more resilient supply chain for excipients

Ahead of CPHI, which is back in Frankfurt this year from 1–3 November with visitor numbers expected to meet or exceed prepandemic levels, Iain Moor...

Malvern Panalytical and Applied Photophysics announce distribution agreement

Partnership targets high-throughput protein stability screening to accelerate drug development

What should be behind the surge in supply chain scenario planning?

Supply chain scenario planning has rocketed in almost all industries since the COVID-19 pandemic, continuing a trend that started before the 2020 s...